https://kuraoncology.com/wp-content/uploads/Empowered_Patient_Podcast.jpg450800eallison/wp-content/uploads/kura-logo-registered-blue.svgeallison2024-08-01 15:00:432024-08-01 16:43:02Menin Inhibition Shows Potential for Precision Therapy in AML with Dr. Mollie Leoni, Kura Oncology
https://kuraoncology.com/wp-content/uploads/Nature.jpg450800eallison/wp-content/uploads/kura-logo-registered-blue.svgeallison2024-08-01 13:00:102024-11-06 12:49:06Menin inhibitors seek to debut as newest targeted therapy for leukaemia
https://kuraoncology.com/wp-content/uploads/MovingForwad_GivngBack.jpg450800eallison/wp-content/uploads/kura-logo-registered-blue.svgeallison2024-06-27 13:00:032024-06-28 10:28:21Moving Forward, Giving Back: The ROI of Social Impact
https://kuraoncology.com/wp-content/uploads/OncLive.png304557eallison/wp-content/uploads/kura-logo-registered-blue.svgeallison2024-03-21 18:38:282024-03-21 19:49:24Ziftomenib Combos Show Early Safety, Activity in NPM1-Mutant and KMT2A-Rearranged AML
https://kuraoncology.com/wp-content/uploads/Precision_Medicine_Online.png304557eallison/wp-content/uploads/kura-logo-registered-blue.svgeallison2024-03-21 18:20:582024-11-06 12:12:16Kura Oncology Reports Preliminary Data From Menin Inhibitor, Chemo Combination Trial in AML
https://kuraoncology.com/wp-content/uploads/fierce_bio.png304557eallison/wp-content/uploads/kura-logo-registered-blue.svgeallison2024-03-21 11:43:012024-03-22 15:20:19Kura’s Leukemia Treatment Performs Best When Tacked Onto Existing Combo, New Data Show
https://kuraoncology.com/wp-content/uploads/SC2402_Scrip-Asks-24-Part-5_1888758571_1200.jpg444790eallison/wp-content/uploads/kura-logo-registered-blue.svgeallison2024-02-15 13:38:472024-02-15 13:39:44Scrip Asks…What Does 2024 Hold For Biopharma? Part 5: Clinical Trial Trends
https://kuraoncology.com/wp-content/uploads/PV-Outlook.png8521524eallison/wp-content/uploads/kura-logo-registered-blue.svgeallison2024-01-09 10:44:432024-01-09 11:08:08PharmaVoice’s Crystal Ball: Perspectives on the financial future
https://kuraoncology.com/wp-content/uploads/Kathy-Ford-podcast-image.jpg7922142David Anderson/wp-content/uploads/kura-logo-registered-blue.svgDavid Anderson2023-12-20 17:25:442023-12-21 15:55:25Kathy Ford, R.N., B.S.N., Kura COO, on Ordinarily Extraordinary – Conversations with Women in STEM podcast
https://kuraoncology.com/wp-content/uploads/Manu_Supply_Chain.jpg375710eallison/wp-content/uploads/kura-logo-registered-blue.svgeallison2023-12-01 15:14:492023-12-07 11:34:23Manufacturing And Supply Chain: Making Space Between A Rock And A Hard Place